It is a pharma private limited company based in Pune, Maharashtra, India, established in 2016.
2016 | Pune, Maharashtra, India | ActiveUniswen Pharmaceuticals Private Limited, a active private limited company, was established on 14 June 2016 in Pune, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U85100PN2016PTC164976. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Yashwant Shivram Bhujbal (Additional Director), Shailesh Shashikant Phaldessai (Director), Rajendra Chandrashekhar Dixit (Director). Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at Sno 82, 7A7B8, Bldg No D4/5 Guru Ganesh Nagar, Kothrud, Pune, Maharashtra, 411029.
U85100PN2016PTC164976
164976
14 June 2016
₹0.50 M
₹0.50 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Uniswen Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yashwant Shivram Bhujbal | Additional Director | 14 Jun 2017 | Current |
| Shailesh Shashikant Phaldessai | Director | 14 Jun 2016 | Current |
| Rajendra Chandrashekhar Dixit | Director | 14 Jun 2016 | Current |
| Pandit Vilasrao Ghorpade | Director | 14 Jun 2016 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Uniswen Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 33.98% increase. The company also saw a substantial fall in profitability, with a 14062.17% decrease in profit. The company's net worth observed a substantial decline by a decrease of 570.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Uniswen Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Uniswen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Uniswen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uniswen Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Uniswen Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was documented.
Uniswen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Pune. was recorded as a recent event.
The activity Yashwant Shivram Bhujbal was appointed as a Additional Director was appointed as a Additional Director on 14 Jun 2017 & has been associated with this company since 8 years 5 months . was completed.
Shailesh Shashikant Phaldessai was appointed as a Director was appointed as a Director on 14 Jun 2016 & has been associated with this company since 9 years 5 months . was recorded as a recent event.
Progress on Rajendra Chandrashekhar Dixit was appointed as a Director was appointed as a Director on 14 Jun 2016 & has been associated with this company since 9 years 5 months . was documented.
Pandit Vilasrao Ghorpade was appointed as a Director was appointed as a Director on 14 Jun 2016 & has been associated with this company since 9 years 5 months . was recorded as a recent event.
The CIN of Uniswen Pharmaceuticals Private Limited is U85100PN2016PTC164976.
Uniswen Pharmaceuticals Private Limited is headquartered at Sno 82, 7A7B8, Bldg No D4/5 Guru Ganesh Nagar, Kothrud, Pune, Maharashtra, 411029.
Uniswen Pharmaceuticals Private Limited was incorporated on 14 June 2016.
The current directors of Uniswen Pharmaceuticals Private Limited are
The primary industry of Uniswen Pharmaceuticals Private Limited is Pharma.
Uniswen Pharmaceuticals Private Limited is unlisted.
The authorized capital of Uniswen Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Uniswen Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX